Over the past few months, Anthropic scientists have engaged in deep research partnerships with six organizations developing new medicines. We've also begun drug discovery efforts of our own. In doing so, we’ve learned much more about how Claude can support the many stages of drug development. In this blog post, we share some early results from these efforts, and describe how this work fits in with our wider ambitions in the life sciences.Read original on X
StoryFirst seen
Anthropic starts its own drug discovery work alongside six partners
The move puts the AI lab in direct territory of the drug developers that buy its models.
Everything it touches
2 names 3 voices 3 source posts
The story’s neighborhood
Explore the graph, or choose a connection below.
Follow the evidence
The source posts
This brief comes from Tech Twitter’s edited headlines. The posts below are the sources grouped with the story; statements in them belong to their authors.
Just one day after filing for its IPO, Anthropic announces it’s getting into drug discovery ITSELF. so basically the AI company that sells tokens to an entire industry may eventually compete with its own customers.Read original on X
Anthropic says it has started its own Claude-assisted drug discovery while partnering with six medicine makers, and it says early work has improved lab design, paperwork review and clinical planning.Read original on X
How the headline evolved
Anthropic starts its own drug discovery work alongside six partners
Anthropic begins its own drug discovery work alongside six partners
Anthropic starts its own drug discovery work alongside six partners
Anthropic begins its own drug discovery work alongside partner research
Shared connections
Related stories
Claude for Legal adds ready-made artifacts for contract review
The gallery lets teams share the same legal workflows across the business, starting from a built-in example.
Anthropic starts its own drug discovery work alongside six partners
The move puts the AI lab in direct territory of the drug developers that buy its models.
Anthropic's IPO filing shows $11.6 billion in second-quarter revenue
Revenue from existing customers grew ninefold in a year, which raises pressure on rival OpenAI as it competes for business buyers.
Banks to finance $63 billion of Broadcom chips for Anthropic
The leasing vehicle shows how large AI compute purchases are being financed through Wall Street rather than the AI lab's own balance sheet.